Where does Fox Chase Cancer Center rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Fox Chase Cancer Center ranks #26,337 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Fox Chase Cancer Center hold?

Fox Chase Cancer Center holds 10 US utility patents granted between 2015 and 2019, spanning 13 technology areas.

What is Fox Chase Cancer Center's Innovation Score?

Fox Chase Cancer Center has an Innovation Score of 29.0 out of 100 (top 71% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Fox Chase Cancer Center's patent grant rate increasing or decreasing?

Fox Chase Cancer Center's recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Fox Chase Cancer Center's patents?

Fox Chase Cancer Center's patents average 13.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Fox Chase Cancer Center patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Fox Chase Cancer Center

Q: What technology areas does Fox Chase Cancer Center focus on?

Fox Chase Cancer Center's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 7 patents. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 13 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Fox ranks #26,337 of 50,000 tracked US assignees by granted-patent volume, with 10 patents across 13 technology areas.

#26,337
of 50,000 US assignees by volume: Top 71%
by Innovation Score (29.0/100): 13.3
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26337 · US Corporation #26,337 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,337/50,000
PHOTO-FINISH Fort Wayne Metals Re…
CPC-FOCUS A61P · 13 areas
INNOV-THIN 29.0/100
CLAIMS-RICH 13.3 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Fort Wayne Metals Research Products, Llc (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Buemach Engineering… · near

29
Industries RAD · near

29
JIAO Hsiung Industry · near

29
Nottingham Universit… · near

29
Fox Chase Cancer Cen… · this assignee

29
3D Lighting Innovati… · lowest

7

What this shows Fox's Innovation Score is 29.0/100 (top 71% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Fox's grants concentrate

Fox Chase Cancer Center is a focused PatentsView assignee: 13 CPC subclasses with 70% of grants classified under A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2017. By volume, Fox sits between Fort Wayne Metals Research Products, Llc and Fujita Health University.

Fort Wayne Metals…

10
Foster Findlay As…

10
Fourds

10
Fourté Internatio…

10
Freedman Seating

10
Freedom Solutions…

10
Frequency IP Hold…

10
Fujita Health Uni…

10
Fox Chase Cancer… ◀

10

What this shows Fox holds 10 patents at rank #26,343, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Fox

By rank, the assignees closest to #26,343 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Fox's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Fox, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (29 here).

JIAO Hsiung Industry Corp. 29 Buemach Engineering International B.v. 29 Industries RAD Inc. 29 Nottingham University Hospitals NHS Trust 29

Fox's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 Top 71% higher than 29% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Fox Chase Cancer Center patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	40.0%
2016	4	40.0%
2017	1	10.0%
2019	1	10.0%

Which technologies does Fox Chase Cancer Center patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 7

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 6

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 4

C07K - PEPTIDES 4

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 1

A61G - TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS ; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES 1

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 1

C07D - HETEROCYCLIC COMPOUNDS 1

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 1

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 1

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 1

Top 13 of 13 technology areas

Where it ranks

Overall rank by patents

#26,337

of 50,000 tracked assignees

Innovation Score

29.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.